Elderly patients with head and neck cancer: The influence of comorbidity on choice of therapy, complication rate, and survival

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 13, Issue 2, 2005, Pages 92-96

  Derks, Wynia ^a   De Leeuw, Rob J ^a   Hordijk, Gerrit Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aged; Comorbidity; Head and neck neoplasms; Postoperative complications; Survival rate; Therapy

Indexed keywords

AGING; CARDIOVASCULAR DISEASE; COMORBIDITY; DECISION MAKING; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; INTENSIVE CARE; KIDNEY DISEASE; LUNG DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

AGE FACTORS; AGED; COMORBIDITY; DECISION MAKING; HEAD AND NECK NEOPLASMS; HUMANS; PROGNOSIS; TREATMENT OUTCOME;

EID: 15244363742     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000156169.63204.39     Document Type: Review

References (49)

1. Sarini J, Fournier C, Lefebvre JL, et al. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 2001; 127:1089-1092.
2. Derks W, De Leeuw JR, Hordijk GJ, et al. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol 2004. (In press)
3. Ogle KS, Swanson GM, Woods N, et al. Cancer and comorbidity: redefining chronic diseases. Cancer 2000; 88:653-663.
4. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974; 27:387-404.
5. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47:1245-1251.
6. Greenfield S, Apolone G, McNeil BJ, et al. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: comorbidity and outcomes after hip replacement. Med Care 1993; 31:141-154.
7. Linn BS, Linn MW, Gurel L. Cumulative Illness Rating Scale. J Am Geriatr Soc 1968; 16:622-626.
8. Piccirillo JF, Costas I, Claybour P, et al. The measurement of comorbidity by cancer registries. J Registry Manage 2003; 30:8-14.
9. Hall SF, Rochon PA, Streiner DL, et al. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002; 112:1988-1996.
10. Singh B, Bhaya M, Stern J, et al. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997; 107:1469-1475.
11. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000; 36:453-471.
12. Paleri V, Wight RG. Applicability of the adult comorbidity evaluation-27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol 2002; 116:200-205.
13. Piccirillo JF, Lacy PD, Basu A, et al. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002; 128:1172-1179.
14. Reid BC, Alberg AJ, Klassen AC, et al. A comparison of three comorbidity indexes in a head and neck cancer population. Oral Oncol 2002; 38:187-194.
15. Piccirillo JF, Spitznagel EL Jr, Vermani N, et al. Comparison of comorbidity indices for patients with head and neck cancer. Med Care 2004; 42:482-486. This study compared two general and two disease-specific comorbidity instruments in a cohort of 7131 elderly patients with head and neck cancer.
16. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53:1258-1267.
17. Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16:1582-1587.
18. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14:61-65.
19. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
20. Fee WE Jr. Surgery in the aging population. Arch Otolaryngol Head Neck Surg 1999; 125:1405-1407.
21. Clayman GL, Eicher SA, Sicard MW, et al. Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 1998; 20:216-223.
22. Rapidis AD, Keramidas T, Panagiotopoulos H, et al. Tumours of the head and neck in the elderly: analysis of 190 patients. J Craniomaxillofac Surg 1998; 26:153-158.
23. Singh B, Alfonso A, Sabin S, et al. Outcome differences in younger and older patients with laryngeal cancer: a retrospective case-control study. Am J Otolaryngol 2000; 21:92-97.
24. Derks W, de Leeuw JR, Hordijk GJ, et al. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol 2003; 28:399-405.
25. Beausang ES, Ang EE, Lipa JE, et al. Microvascular free tissue transfer in elderly patients: the Toronto experience. Head Neck 2003; 25:549-553. This study compared the postoperative complications in 288 older and younger patients who needed a free flap reconstruction.
26. Satariano WA, Silliman RA. Comorbidity: implications for research and practice in geriatric oncology. Crit Rev Oncol Hematol 2003; 48:239-248.
27. Ambrogi V, Pompeo E, Elia S, et al. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardiothorac Surg 2003; 23:811-817.
28. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000; 35:181-200.
29. Blair SL, Schwarz RE. Advanced age does not contribute to increased risks or poor outcome after major abdominal operations. Am Surg 2001; 67:1123-1127.
30. Birim O, Zuydendorp HM, Maat AP, et al. AJ. Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg 2003; 76:1796-1801.
31. Borggreven PA, Kuik DJ, Quak JJ, et al. Comorbid condition as a prognostic factor for complications in major surgery of the oral cavity and oropharynx with microvascular soft tissue reconstruction. Head Neck 2003; 25:808-815.
32. Suh JD, Sercarz JA, Abemayor E, et al. Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction. Arch Otolaryngol Head Neck Surg 2004; 130:962-966.
33. Blackwell KE, Azizzadeh B, Ayala C, et al. Octogenarian free flap reconstruction: complications and cost of therapy. Otolaryngol Head Neck Surg 2002; 126:301-306.
34. Shaari CM, Buchbinder D, Costantino PD, et al. Complications of microvascular head and neck surgery in the elderly. Arch Otolaryngol Head Neck Surg 1998; 124:407-411.
35. Singh B, Cordeiro PG, Santamaria E, et al. Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 1999; 103:403-411.
36. Haughey BH, Wilson E, Kluwe L, et al. Free flap reconstruction of the head and neck: analysis of 241 cases. Otolaryngol Head Neck Surg 2001; 125:10-17.
37. Allal AS, Maire D, Becker M, et al. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer 2000; 88:648-652.
38. Zachariah B, Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin North Am 2000; 14:131-167.
39. Airoldi M, Cortesina G, Giordano C, et al. Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130:161-166.
40. Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291:2441-2447. This large chart review of 17, 712 patients showed that comorbidity is an important independent prognostic factor in patients with all kinds of cancer, including head and neck cancer.
41. Reid BC, Alberg AJ, Klassen AC, et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001; 92:2109-2116.
42. Hall SF, Groome PA, Rothwell D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck 2000; 22:317-322.
43. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000; 110:593-602.
44. Sabin SL, Rosenfeld RM, Sundaram K, et al. The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 1999; 78:581-584.
45. Ribeiro KC, Kowalski LP, Latorre MR. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000; 126:1079-1085.
46. Paleri V, Wight RG, Davies GR. Impact of comorbidity on the outcome of laryngeal squamous cancer. Head Neck 2003; 25:1019-1026.
47. Cassia Braga RK, Kowalski LP, Latorre MR. Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 2003; 129:219-228. This study showed that age is not associated with survival in a cohort of 530 patients with oral and oropharyngeal cancer.
48. Chen AY, Matson LK, Roberts D, et al. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001; 23:566-572.
49. Derks W, De Leeuw RJ, Hordijk GJ, et al. Quality of life in elderly patients with head and neck cancer one year after diagnosis. Head Neck 2004; 26:1045-1052. This prospective study demonstrated that there are no differences in quality of life for as long as 1 year after treatment for head and neck cancer between patients aged 70 years and older and younger patients.